Poland – Pharmaceutical products – Dostawa leków i płynów infuzyjnych
Description
1. The subject of the contract are successive deliveries of pharmaceuticals and infusion fluids, divided into 9 lots, as ordered by the Contracting Authority. 2. The detailed description of the subject of the contract, including the assortment, doses, forms, and quantities, is specified in Annex No. 2 to the SWZ – Price and Product List. 3. The assortment that is the subject of the contract must be approved for sale and use in the territory of the Republic of Poland in accordance with the Act of 6 September 2001 – Pharmaceutical Law (consolidated text: Journal of Laws 2026 item 612). The Contractor is obligated to possess all the documents required by law to approve the offered medicinal products for sale and to present them upon request by the Contracting Authority (with the exception of medicinal products imported under the direct import procedure). 4. In the submitted tenders, the commercial name of the preparation, the size of the packaging, the name of the manufacturer, the GTIN/EAN code, the permit number allowing for sale, and detailed information about the product must be provided. In cases where the offered drug packaging contains a different number of units (e.g. tablets, ampoules), the Contractor is obligated to convert the quantity of packages accordingly. In cases where an incomplete number of packages is received, the quantity should be rounded up to the nearest full package. The EAN (GTIN) code indicated in the Price and Product List is for informational purposes only and serves to identify the offered product on the date of tender submission. A change in the EAN (GTIN) code during the period of the contract's validity, resulting from a change in packaging, distributor, or trade name, while maintaining the same active substance, dose, pharmaceutical form, and permit number for sale, does not constitute a change in the tender content or a change in the contract. 5. The Contracting Authority allows the exchange of tablets for capsules (and vice versa), and the exchange of ampoules for vials (and vice versa), provided that the same form of the drug is maintained. However, the Contracting Authority does not allow the exchange of prolonged-release and modified-release drugs for drugs in the form of a classic tablet, dragee, or capsule. 6. The Contracting Authority requires that, in order to maintain the safety of pharmacotherapy, different doses of the same medicinal product contained in one Task come from one manufacturer - this applies to the same form of the drug.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Poland – Medical consumables – DFP.271.218.2026.EP Dostawa materiałów aptecznych
SZPITAL UNIWERSYTECKI W KRAKOWIEPolandMedical consumablesDeadline in 37 daysPublished on Nov 19, 2026
Poland – Pharmaceutical products – „Sukcesywna dostawa leków medycyny ludzkiej na potrzeby wydziału Medycyny Weterynaryjnej UWM w Olsztynie”
UNIWERSYTET WARMIŃSKO-MAZURSKI W OLSZTYNIEPolandPharmaceutical productsDeadline in 36 daysPublished on Nov 19, 2026
Poland – Laboratory reagents – Dostawa odczynników do biologii komórkowej, molekularnej oraz do izolacji, wykrywania na podstawie umów ramowych
Sieć Badawcza Łukasiewicz - PORT Polski Ośrodek Rozwoju TechnologiiPolandLaboratory reagentsDeadline in 29 daysPublished on Nov 19, 2026
Poland – Medical consumables – Dostawa materiałów eksploatacyjnych do diatermii chirurgicznych ERBE
Centrum Onkologii im. Franciszka Łukaszczyka w BydgoszczyPolandMedical consumablesDeadline in 30 daysPublished on Nov 19, 2026